Evidence map›Paper›PMID 33489048›Full record

ArticleMediterranean journal of hematology and infectious diseases2021

Peripheral Blood Smear Findings of COVID-19 Patients Provide İnformation about the Severity of the Disease and the Duration of Hospital Stay.

Ilhami Berber, Ozlem Cagasar, Ahmet Sarici, Nurcan Kirici Berber, Ismet Aydogdu, Ozkan Ulutas, Asli Yildirim, Harika Gozde Gozukara Bag, Leman Acun Delen

Open access · goldAbstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Nanoparticle Transport in Proximal Tubules with Rhabdomyolysis-Induced Necrosis.Angewandte Chemie (International ed. in English) · 2025
    Article
  5. MDS-Type Morphologic Abnormalities of Peripheral Blood Granulocytes in Symptomatic COVID-19 Patients.International journal of hematology-oncology and stem cell research · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of inflammatory indices in the outcome of COVID-19 cancer patients.Medical oncology (Northwood, London, England) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ilhami BerberInonu University Adult Hematology Department, Malatya / Turkey.
Ozlem CagasarMalatya Training and Research Hospital, Department of Infectious Diseases, Malatya / Turkey.
Ahmet SariciInonu University Adult Hematology Department, Malatya / Turkey.
Nurcan Kirici BerberMalatya Training and Research Hospital, Chest Diseases Department, Malatya / Turkey.
Ismet AydogduCelal Bayar University Adult Hematology Department, Manisa / Turkey.
Ozkan UlutasInonu University Internal Medicine Department, Malatya / Turkey.
Asli YildirimMalatya Training and Research Hospital, Department of Medical Oncology, Malatya / Turkey.
Harika Gozde Gozukara BagInonu University Biostatistics Department, Malatya / Turkey.
Leman Acun DelenMalatya Training and Research Hospital, Anesthesiology Department, Malatya / Turkey.
Inonu University · TRMalatya Devlet Hastanesi · TRManisa Celal Bayar University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData about the morphological changes in peripheral blood smears during COVID-19 infection and their clinical severity association are limited. We aimed to examine the characteristics of the cells detected in the pathological rate and/or appearance and whether these findings are related to the clinical course by evaluating the peripheral blood smear at the time of diagnosis in COVID-19 patients.

methodsClinical features, laboratory data, peripheral blood smear of fifty patients diagnosed with COVID-19 by PCR was evaluated at diagnosis. Peripheral smear samples of the patients were compared with the age and sex-matched 30 healthy controls. Pictures were taken from the patient's peripheral blood smear. Patients were divided into two groups. Mild and severe stage patient groups were compared in terms of laboratory data and peripheral smear findings. The relationship between the laboratory values of all patients and the duration of hospitalization was analyzed.

resultsThe number of segmented neutrophils and eosinophils were low, pseudo-Pelger-Huet, pseudo-Pelger-Huet/mature lymphocyte ratio, atypical lymphocytes, monocytes with vacuoles, bands, and pyknotic neutrophils rates were higher in the peripheral blood smear of the patient group (p <0.05). Increased pseudo-Pelger-Huet anomaly, pseudo-Pelger Huet/mature lymphocyte ratio, a decreased number of mature lymphocytes, and eosinophils in peripheral blood smear were observed in the severe stage patients (p <0.05). A negative correlation was observed between hospitalization duration and mature lymphocyte and monocytes with vacuoles rates (p <0.05).

conclusionA peripheral blood smear is an inexpensive, easily performed, and rapid test. Increased Pseudo-Pelger-Huet anomaly/mature lymphocyte rate suggests a severe stage disease, while high initial mature lymphocyte and monocytes with vacuoles rates at the time of diagnosis may be an indicator of shortened duration of hospitalization.

Indexed as

Mature lymphocytesMonocytes with vacuolesPseudo-Pelger Huet anomalySevere COVID-19

Identifiers

PMID33489048
PMCPMC7813282
OpenAlexW3118437169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.